返回
Guangzhou Innogen Pharmaceutical Group Co., Ltd（02591.HK）价格
02591.HK 股价走势图
INNOGEN-B (02591.HK)
Guangzhou Innogen Pharmaceutical Group Co., Ltd
HK$30.86
0.19%
$0.05
休市： Jan 19, 16:00:00 HKT
关键数据
前收盘价
$30.98
开盘价
$30.8
当日区间
$30.52 - $31.24
52周范围
$28.4 - $74
交易量
219.2K
平均成交量
674.8K
每股收益（TTM）
-0.54
股息收益率
--
市值
$12.9B
什么是 INNOGEN-B？
Guangzhou Innogen Pharmaceutical Group Co., Ltd. engages in the production and distribution of pharmaceutical products. The company is headquartered in Guangzhou, Guangdong and currently employs 105 full-time employees. The company went IPO on 2025-08-15. The firm is primarily engaged in the commercialization of innovative, humanized, long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. The firm is dedicated to developing therapies for diabetes and other metabolic diseases. The Company’s core product, Efsubaglutide Alfa (brand name: Diabegone), is used for the treatment of type 2 diabetes (T2D). The Company’s primary pipeline drug candidates include YN014, YN401, YN209, YN203, and YN202. The firm principally conducts its businesses in the domestic market.